URGN NASDAQ
UroGen Pharma Ltd.
1W: +0.1%
1M: -6.8%
3M: +10.7%
YTD: +82.3%
1Y: +132.3%
3Y: +174.3%
5Y: +144.2%
$41.40
+0.85 (+2.10%)
Weekly Expected Move ±4.8%
$37
$39
$41
$43
$45
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$189M
Revenue
+169.5% YoY
$-98M
Net Income
+7.0% YoY
$-159M
Free Cash Flow
-28.8% YoY
90.9%
Gross Margin
0.2%
Op. Margin
-19.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE86.5%
ROA-42.3%
ROIC119.0%
Valuation
P/E-20.9
P/B-15.8
EV/EBITDA-27.5
Leverage
Debt/Equity-1.48
Current Ratio3.80
Interest Cov.-2.1x
Quality Scores
Piotroski F2/9
Altman Z-2.02
Beneish M0.00